跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRAQUIX 25 MICROGRAMOS/250 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BRAQUIX 25 MICROGRAMOS/250 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION
Approved
STANDARD
BRAQUIX 25 MICROGRAMOS/250 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION
Mabo Farma S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 21, 2022
Approval ID
c96f3bfa1eb2365c
Company
Mabo Farma S.A.
Type
Standard
Approval Details
Approval Id
c96f3bfa1eb2365c
Drug Cima Aemps Name
BRAQUIX 25 MICROGRAMOS/250 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION
Register Number
86663
Holder Company Name
Mabo Farma S.A.
Marketing Company Name
Mabo Farma S.A.
Authorization Date
2022-03-21
Dosage Form
SUSPENSIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN
Dose
25 microgramos/250 microgramos
Route Of Administration
VÍA INHALATORIA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Mabo Farma S.A.
Active Ingredients
SALMETEROL XINAFOATO
36,32 µg
FLUTICASONA PROPIONATO
250 µg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 21, 2022
Approval ID
c96f3bfa1eb2365c
Type
Standard
Back to CIMA-AEMPS Approvals